nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB2—prostate cancer	0.499	1	CbGaD
Oxprenolol—SLC22A2—Estradiol—prostate cancer	0.105	0.409	CbGbCtD
Oxprenolol—CYP2D6—Bicalutamide—prostate cancer	0.0768	0.298	CbGbCtD
Oxprenolol—CYP2D6—Abiraterone—prostate cancer	0.0636	0.247	CbGbCtD
Oxprenolol—CYP2D6—Doxorubicin—prostate cancer	0.0118	0.0457	CbGbCtD
Oxprenolol—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.000731	0.00511	CcSEcCtD
Oxprenolol—Dyspepsia—Cabazitaxel—prostate cancer	0.000729	0.0051	CcSEcCtD
Oxprenolol—Fatigue—Cabazitaxel—prostate cancer	0.000714	0.00499	CcSEcCtD
Oxprenolol—Asthenia—Nilutamide—prostate cancer	0.000706	0.00494	CcSEcCtD
Oxprenolol—Asthenia—Flutamide—prostate cancer	0.000703	0.00492	CcSEcCtD
Oxprenolol—Dizziness—Estrone—prostate cancer	0.000701	0.0049	CcSEcCtD
Oxprenolol—Pruritus—Nilutamide—prostate cancer	0.000696	0.00487	CcSEcCtD
Oxprenolol—Thrombocytopenia—Bicalutamide—prostate cancer	0.000696	0.00486	CcSEcCtD
Oxprenolol—Abdominal pain—Degarelix—prostate cancer	0.000695	0.00486	CcSEcCtD
Oxprenolol—Headache—Estramustine—prostate cancer	0.000695	0.00486	CcSEcCtD
Oxprenolol—Pruritus—Flutamide—prostate cancer	0.000693	0.00485	CcSEcCtD
Oxprenolol—Hyperhidrosis—Bicalutamide—prostate cancer	0.000687	0.0048	CcSEcCtD
Oxprenolol—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000681	0.00476	CcSEcCtD
Oxprenolol—Bronchospasm—Estradiol—prostate cancer	0.000678	0.00474	CcSEcCtD
Oxprenolol—Diarrhoea—Nilutamide—prostate cancer	0.000673	0.00471	CcSEcCtD
Oxprenolol—Sweating increased—Estradiol—prostate cancer	0.000671	0.00469	CcSEcCtD
Oxprenolol—Diarrhoea—Flutamide—prostate cancer	0.00067	0.00469	CcSEcCtD
Oxprenolol—Headache—Estrone—prostate cancer	0.000664	0.00464	CcSEcCtD
Oxprenolol—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000664	0.00464	CcSEcCtD
Oxprenolol—Nausea—Estramustine—prostate cancer	0.000659	0.00461	CcSEcCtD
Oxprenolol—Abdominal pain—Cabazitaxel—prostate cancer	0.000655	0.00458	CcSEcCtD
Oxprenolol—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000654	0.00458	CcSEcCtD
Oxprenolol—Dizziness—Nilutamide—prostate cancer	0.000651	0.00455	CcSEcCtD
Oxprenolol—Dizziness—Flutamide—prostate cancer	0.000648	0.00453	CcSEcCtD
Oxprenolol—Hypersensitivity—Degarelix—prostate cancer	0.000648	0.00453	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.000647	0.00453	CcSEcCtD
Oxprenolol—Insomnia—Bicalutamide—prostate cancer	0.000643	0.00449	CcSEcCtD
Oxprenolol—Acebutolol—SLC22A1—prostate cancer	0.000642	0.101	CrCbGaD
Oxprenolol—Metipranolol—ADRB2—prostate cancer	0.00064	0.101	CrCbGaD
Oxprenolol—Cardiac failure—Etoposide—prostate cancer	0.000633	0.00443	CcSEcCtD
Oxprenolol—Asthenia—Degarelix—prostate cancer	0.000631	0.00441	CcSEcCtD
Oxprenolol—Nausea—Estrone—prostate cancer	0.000629	0.0044	CcSEcCtD
Oxprenolol—Dyspepsia—Bicalutamide—prostate cancer	0.000625	0.00437	CcSEcCtD
Oxprenolol—Sweating increased—Mitoxantrone—prostate cancer	0.000625	0.00437	CcSEcCtD
Oxprenolol—Pruritus—Degarelix—prostate cancer	0.000622	0.00435	CcSEcCtD
Oxprenolol—Headache—Nilutamide—prostate cancer	0.000617	0.00431	CcSEcCtD
Oxprenolol—Headache—Flutamide—prostate cancer	0.000614	0.00429	CcSEcCtD
Oxprenolol—Fatigue—Bicalutamide—prostate cancer	0.000613	0.00428	CcSEcCtD
Oxprenolol—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000612	0.00428	CcSEcCtD
Oxprenolol—Hypersensitivity—Cabazitaxel—prostate cancer	0.00061	0.00427	CcSEcCtD
Oxprenolol—Diarrhoea—Degarelix—prostate cancer	0.000602	0.00421	CcSEcCtD
Oxprenolol—Asthenia—Cabazitaxel—prostate cancer	0.000594	0.00416	CcSEcCtD
Oxprenolol—Nausea—Nilutamide—prostate cancer	0.000585	0.00409	CcSEcCtD
Oxprenolol—Nausea—Flutamide—prostate cancer	0.000582	0.00407	CcSEcCtD
Oxprenolol—Dizziness—Degarelix—prostate cancer	0.000581	0.00407	CcSEcCtD
Oxprenolol—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000579	0.00405	CcSEcCtD
Oxprenolol—Diarrhoea—Cabazitaxel—prostate cancer	0.000567	0.00396	CcSEcCtD
Oxprenolol—Abdominal pain—Bicalutamide—prostate cancer	0.000562	0.00393	CcSEcCtD
Oxprenolol—Headache—Degarelix—prostate cancer	0.000551	0.00385	CcSEcCtD
Oxprenolol—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000549	0.00384	CcSEcCtD
Oxprenolol—Dizziness—Cabazitaxel—prostate cancer	0.000548	0.00383	CcSEcCtD
Oxprenolol—Palpitations—Goserelin—prostate cancer	0.000535	0.00374	CcSEcCtD
Oxprenolol—Palpitations—Conjugated Estrogens—prostate cancer	0.00053	0.00371	CcSEcCtD
Oxprenolol—Cardiac failure—Docetaxel—prostate cancer	0.000526	0.00368	CcSEcCtD
Oxprenolol—Bronchospasm—Etoposide—prostate cancer	0.000525	0.00367	CcSEcCtD
Oxprenolol—Hypersensitivity—Bicalutamide—prostate cancer	0.000523	0.00366	CcSEcCtD
Oxprenolol—Bradycardia—Mitoxantrone—prostate cancer	0.000523	0.00366	CcSEcCtD
Oxprenolol—Nausea—Degarelix—prostate cancer	0.000522	0.00365	CcSEcCtD
Oxprenolol—Sweating increased—Etoposide—prostate cancer	0.00052	0.00364	CcSEcCtD
Oxprenolol—Headache—Cabazitaxel—prostate cancer	0.000519	0.00363	CcSEcCtD
Oxprenolol—Fatigue—Ethinyl Estradiol—prostate cancer	0.000518	0.00362	CcSEcCtD
Oxprenolol—Arthralgia—Goserelin—prostate cancer	0.000516	0.00361	CcSEcCtD
Oxprenolol—Arthralgia—Conjugated Estrogens—prostate cancer	0.000511	0.00357	CcSEcCtD
Oxprenolol—Asthenia—Bicalutamide—prostate cancer	0.00051	0.00356	CcSEcCtD
Oxprenolol—Cardiac failure—Capecitabine—prostate cancer	0.000509	0.00356	CcSEcCtD
Oxprenolol—Esmolol—ADRB2—prostate cancer	0.000509	0.0803	CrCbGaD
Oxprenolol—Pruritus—Bicalutamide—prostate cancer	0.000503	0.00352	CcSEcCtD
Oxprenolol—Diplopia—Capecitabine—prostate cancer	0.000497	0.00348	CcSEcCtD
Oxprenolol—Nausea—Cabazitaxel—prostate cancer	0.000492	0.00344	CcSEcCtD
Oxprenolol—Diarrhoea—Bicalutamide—prostate cancer	0.000486	0.0034	CcSEcCtD
Oxprenolol—Thrombocytopenia—Goserelin—prostate cancer	0.000484	0.00338	CcSEcCtD
Oxprenolol—Hyperhidrosis—Goserelin—prostate cancer	0.000478	0.00334	CcSEcCtD
Oxprenolol—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000475	0.00332	CcSEcCtD
Oxprenolol—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000473	0.00331	CcSEcCtD
Oxprenolol—Abnormal dreams—Epirubicin—prostate cancer	0.000472	0.0033	CcSEcCtD
Oxprenolol—Dizziness—Bicalutamide—prostate cancer	0.00047	0.00329	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Docetaxel—prostate cancer	0.000469	0.00328	CcSEcCtD
Oxprenolol—Hypotension—Goserelin—prostate cancer	0.000462	0.00323	CcSEcCtD
Oxprenolol—Hypotension—Conjugated Estrogens—prostate cancer	0.000457	0.0032	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Capecitabine—prostate cancer	0.000454	0.00318	CcSEcCtD
Oxprenolol—Cardiac failure—Prednisone—prostate cancer	0.000454	0.00317	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Goserelin—prostate cancer	0.00045	0.00315	CcSEcCtD
Oxprenolol—Betaxolol—ADRB2—prostate cancer	0.000448	0.0707	CrCbGaD
Oxprenolol—Insomnia—Goserelin—prostate cancer	0.000447	0.00313	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000446	0.00312	CcSEcCtD
Oxprenolol—Headache—Bicalutamide—prostate cancer	0.000445	0.00311	CcSEcCtD
Oxprenolol—Atenolol—ADRB2—prostate cancer	0.000444	0.0701	CrCbGaD
Oxprenolol—Penbutolol—ADRB2—prostate cancer	0.000444	0.0701	CrCbGaD
Oxprenolol—Insomnia—Conjugated Estrogens—prostate cancer	0.000443	0.0031	CcSEcCtD
Oxprenolol—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000442	0.00309	CcSEcCtD
Oxprenolol—Bronchospasm—Docetaxel—prostate cancer	0.000437	0.00305	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—prostate cancer	0.000436	0.00305	CcSEcCtD
Oxprenolol—Dyspepsia—Goserelin—prostate cancer	0.000435	0.00304	CcSEcCtD
Oxprenolol—Bisoprolol—ADRB2—prostate cancer	0.000433	0.0683	CrCbGaD
Oxprenolol—Psychotic disorder—Prednisone—prostate cancer	0.000432	0.00302	CcSEcCtD
Oxprenolol—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000431	0.00301	CcSEcCtD
Oxprenolol—Asthenia—Ethinyl Estradiol—prostate cancer	0.000431	0.00301	CcSEcCtD
Oxprenolol—Fatigue—Goserelin—prostate cancer	0.000426	0.00298	CcSEcCtD
Oxprenolol—Pruritus—Ethinyl Estradiol—prostate cancer	0.000425	0.00297	CcSEcCtD
Oxprenolol—Palpitations—Estradiol—prostate cancer	0.000424	0.00297	CcSEcCtD
Oxprenolol—Bronchospasm—Capecitabine—prostate cancer	0.000423	0.00296	CcSEcCtD
Oxprenolol—Fatigue—Conjugated Estrogens—prostate cancer	0.000422	0.00295	CcSEcCtD
Oxprenolol—Nausea—Bicalutamide—prostate cancer	0.000422	0.00295	CcSEcCtD
Oxprenolol—Sweating increased—Capecitabine—prostate cancer	0.000419	0.00293	CcSEcCtD
Oxprenolol—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000411	0.00287	CcSEcCtD
Oxprenolol—Acebutolol—ADRB2—prostate cancer	0.00041	0.0647	CrCbGaD
Oxprenolol—Arthralgia—Estradiol—prostate cancer	0.000409	0.00286	CcSEcCtD
Oxprenolol—Dizziness—Ethinyl Estradiol—prostate cancer	0.000397	0.00278	CcSEcCtD
Oxprenolol—Abdominal pain—Goserelin—prostate cancer	0.000391	0.00273	CcSEcCtD
Oxprenolol—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000387	0.00271	CcSEcCtD
Oxprenolol—Arthralgia—Mitoxantrone—prostate cancer	0.000381	0.00266	CcSEcCtD
Oxprenolol—Hyperhidrosis—Estradiol—prostate cancer	0.000379	0.00265	CcSEcCtD
Oxprenolol—Headache—Ethinyl Estradiol—prostate cancer	0.000376	0.00263	CcSEcCtD
Oxprenolol—Sweating increased—Prednisone—prostate cancer	0.000373	0.00261	CcSEcCtD
Oxprenolol—Alprenolol—ADRB2—prostate cancer	0.000372	0.0587	CrCbGaD
Oxprenolol—Hypersensitivity—Goserelin—prostate cancer	0.000364	0.00255	CcSEcCtD
Oxprenolol—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000361	0.00252	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000357	0.0025	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000357	0.0025	CcSEcCtD
Oxprenolol—Nausea—Ethinyl Estradiol—prostate cancer	0.000357	0.00249	CcSEcCtD
Oxprenolol—Cardiac failure—Epirubicin—prostate cancer	0.000355	0.00248	CcSEcCtD
Oxprenolol—Hypoglycaemia—Epirubicin—prostate cancer	0.000355	0.00248	CcSEcCtD
Oxprenolol—Asthenia—Goserelin—prostate cancer	0.000355	0.00248	CcSEcCtD
Oxprenolol—Insomnia—Estradiol—prostate cancer	0.000354	0.00248	CcSEcCtD
Oxprenolol—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000353	0.00247	CcSEcCtD
Oxprenolol—Asthenia—Conjugated Estrogens—prostate cancer	0.000351	0.00246	CcSEcCtD
Oxprenolol—Bradycardia—Capecitabine—prostate cancer	0.00035	0.00245	CcSEcCtD
Oxprenolol—Pruritus—Goserelin—prostate cancer	0.00035	0.00245	CcSEcCtD
Oxprenolol—Pruritus—Conjugated Estrogens—prostate cancer	0.000346	0.00242	CcSEcCtD
Oxprenolol—Diplopia—Epirubicin—prostate cancer	0.000346	0.00242	CcSEcCtD
Oxprenolol—Metoprolol—ADRB2—prostate cancer	0.000346	0.0546	CrCbGaD
Oxprenolol—Dyspepsia—Estradiol—prostate cancer	0.000345	0.00241	CcSEcCtD
Oxprenolol—Hypotension—Mitoxantrone—prostate cancer	0.000341	0.00239	CcSEcCtD
Oxprenolol—Diarrhoea—Goserelin—prostate cancer	0.000338	0.00236	CcSEcCtD
Oxprenolol—Fatigue—Estradiol—prostate cancer	0.000338	0.00236	CcSEcCtD
Oxprenolol—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000335	0.00234	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000333	0.00233	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—prostate cancer	0.000328	0.0023	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—prostate cancer	0.000328	0.0023	CcSEcCtD
Oxprenolol—Dizziness—Goserelin—prostate cancer	0.000327	0.00229	CcSEcCtD
Oxprenolol—Dizziness—Conjugated Estrogens—prostate cancer	0.000324	0.00226	CcSEcCtD
Oxprenolol—Dyspepsia—Mitoxantrone—prostate cancer	0.000321	0.00225	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—prostate cancer	0.00032	0.00224	CcSEcCtD
Oxprenolol—Pindolol—ADRB2—prostate cancer	0.00032	0.0505	CrCbGaD
Oxprenolol—Orthostatic hypotension—Epirubicin—prostate cancer	0.000316	0.00221	CcSEcCtD
Oxprenolol—Fatigue—Mitoxantrone—prostate cancer	0.000315	0.0022	CcSEcCtD
Oxprenolol—Bradycardia—Prednisone—prostate cancer	0.000312	0.00218	CcSEcCtD
Oxprenolol—Abdominal pain—Estradiol—prostate cancer	0.00031	0.00217	CcSEcCtD
Oxprenolol—Headache—Goserelin—prostate cancer	0.00031	0.00217	CcSEcCtD
Oxprenolol—Headache—Conjugated Estrogens—prostate cancer	0.000307	0.00214	CcSEcCtD
Oxprenolol—Metoprolol—CYP2C19—prostate cancer	0.000298	0.047	CrCbGaD
Oxprenolol—Thrombocytopenia—Etoposide—prostate cancer	0.000297	0.00208	CcSEcCtD
Oxprenolol—Nausea—Goserelin—prostate cancer	0.000294	0.00205	CcSEcCtD
Oxprenolol—Hyperhidrosis—Etoposide—prostate cancer	0.000294	0.00205	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000293	0.00205	CcSEcCtD
Oxprenolol—Nausea—Conjugated Estrogens—prostate cancer	0.000291	0.00203	CcSEcCtD
Oxprenolol—Hypersensitivity—Estradiol—prostate cancer	0.000289	0.00202	CcSEcCtD
Oxprenolol—Abdominal pain—Mitoxantrone—prostate cancer	0.000289	0.00202	CcSEcCtD
Oxprenolol—Hypotension—Etoposide—prostate cancer	0.000284	0.00198	CcSEcCtD
Oxprenolol—Asthenia—Estradiol—prostate cancer	0.000281	0.00197	CcSEcCtD
Oxprenolol—Pruritus—Estradiol—prostate cancer	0.000277	0.00194	CcSEcCtD
Oxprenolol—Palpitations—Docetaxel—prostate cancer	0.000273	0.00191	CcSEcCtD
Oxprenolol—Hypersensitivity—Mitoxantrone—prostate cancer	0.000269	0.00188	CcSEcCtD
Oxprenolol—Diarrhoea—Estradiol—prostate cancer	0.000268	0.00187	CcSEcCtD
Oxprenolol—Palpitations—Capecitabine—prostate cancer	0.000265	0.00185	CcSEcCtD
Oxprenolol—Arthralgia—Docetaxel—prostate cancer	0.000263	0.00184	CcSEcCtD
Oxprenolol—Asthenia—Mitoxantrone—prostate cancer	0.000262	0.00183	CcSEcCtD
Oxprenolol—Fatigue—Etoposide—prostate cancer	0.000262	0.00183	CcSEcCtD
Oxprenolol—Dizziness—Estradiol—prostate cancer	0.000259	0.00181	CcSEcCtD
Oxprenolol—Arthralgia—Capecitabine—prostate cancer	0.000255	0.00178	CcSEcCtD
Oxprenolol—Diarrhoea—Mitoxantrone—prostate cancer	0.00025	0.00175	CcSEcCtD
Oxprenolol—Thrombocytopenia—Docetaxel—prostate cancer	0.000247	0.00173	CcSEcCtD
Oxprenolol—Headache—Estradiol—prostate cancer	0.000245	0.00172	CcSEcCtD
Oxprenolol—Bradycardia—Epirubicin—prostate cancer	0.000244	0.00171	CcSEcCtD
Oxprenolol—Abdominal pain—Etoposide—prostate cancer	0.00024	0.00168	CcSEcCtD
Oxprenolol—Thrombocytopenia—Capecitabine—prostate cancer	0.000239	0.00167	CcSEcCtD
Oxprenolol—Bisoprolol—CYP3A4—prostate cancer	0.000237	0.0374	CrCbGaD
Oxprenolol—Hyperhidrosis—Capecitabine—prostate cancer	0.000236	0.00165	CcSEcCtD
Oxprenolol—Hypotension—Docetaxel—prostate cancer	0.000236	0.00165	CcSEcCtD
Oxprenolol—Nausea—Estradiol—prostate cancer	0.000233	0.00163	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.00023	0.00161	CcSEcCtD
Oxprenolol—Headache—Mitoxantrone—prostate cancer	0.000229	0.0016	CcSEcCtD
Oxprenolol—Hypotension—Capecitabine—prostate cancer	0.000228	0.0016	CcSEcCtD
Oxprenolol—Insomnia—Docetaxel—prostate cancer	0.000228	0.0016	CcSEcCtD
Oxprenolol—Arthralgia—Prednisone—prostate cancer	0.000227	0.00159	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—prostate cancer	0.000226	0.00158	CcSEcCtD
Oxprenolol—Hypersensitivity—Etoposide—prostate cancer	0.000224	0.00156	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000223	0.00156	CcSEcCtD
Oxprenolol—Dyspepsia—Docetaxel—prostate cancer	0.000222	0.00155	CcSEcCtD
Oxprenolol—Insomnia—Capecitabine—prostate cancer	0.000221	0.00155	CcSEcCtD
Oxprenolol—Propranolol—CYP3A5—prostate cancer	0.000221	0.0349	CrCbGaD
Oxprenolol—Asthenia—Etoposide—prostate cancer	0.000218	0.00152	CcSEcCtD
Oxprenolol—Fatigue—Docetaxel—prostate cancer	0.000218	0.00152	CcSEcCtD
Oxprenolol—Nausea—Mitoxantrone—prostate cancer	0.000217	0.00152	CcSEcCtD
Oxprenolol—Dyspepsia—Capecitabine—prostate cancer	0.000215	0.0015	CcSEcCtD
Oxprenolol—Pruritus—Etoposide—prostate cancer	0.000215	0.0015	CcSEcCtD
Oxprenolol—Fatigue—Capecitabine—prostate cancer	0.000211	0.00147	CcSEcCtD
Oxprenolol—Hyperhidrosis—Prednisone—prostate cancer	0.00021	0.00147	CcSEcCtD
Oxprenolol—Diarrhoea—Etoposide—prostate cancer	0.000208	0.00145	CcSEcCtD
Oxprenolol—Dizziness—Etoposide—prostate cancer	0.000201	0.0014	CcSEcCtD
Oxprenolol—Abdominal pain—Docetaxel—prostate cancer	0.0002	0.0014	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000198	0.00139	CcSEcCtD
Oxprenolol—Insomnia—Prednisone—prostate cancer	0.000197	0.00138	CcSEcCtD
Oxprenolol—Abdominal pain—Capecitabine—prostate cancer	0.000193	0.00135	CcSEcCtD
Oxprenolol—Dyspepsia—Prednisone—prostate cancer	0.000192	0.00134	CcSEcCtD
Oxprenolol—Headache—Etoposide—prostate cancer	0.00019	0.00133	CcSEcCtD
Oxprenolol—Fatigue—Prednisone—prostate cancer	0.000188	0.00131	CcSEcCtD
Oxprenolol—Hypersensitivity—Docetaxel—prostate cancer	0.000186	0.0013	CcSEcCtD
Oxprenolol—Palpitations—Epirubicin—prostate cancer	0.000184	0.00129	CcSEcCtD
Oxprenolol—Asthenia—Docetaxel—prostate cancer	0.000181	0.00127	CcSEcCtD
Oxprenolol—Nausea—Etoposide—prostate cancer	0.00018	0.00126	CcSEcCtD
Oxprenolol—Hypersensitivity—Capecitabine—prostate cancer	0.00018	0.00126	CcSEcCtD
Oxprenolol—Pruritus—Docetaxel—prostate cancer	0.000179	0.00125	CcSEcCtD
Oxprenolol—Arthralgia—Epirubicin—prostate cancer	0.000178	0.00124	CcSEcCtD
Oxprenolol—Asthenia—Capecitabine—prostate cancer	0.000175	0.00123	CcSEcCtD
Oxprenolol—Propranolol—ADRB2—prostate cancer	0.000175	0.0276	CrCbGaD
Oxprenolol—Pruritus—Capecitabine—prostate cancer	0.000173	0.00121	CcSEcCtD
Oxprenolol—Diarrhoea—Docetaxel—prostate cancer	0.000173	0.00121	CcSEcCtD
Oxprenolol—Abdominal pain—Prednisone—prostate cancer	0.000172	0.0012	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—prostate cancer	0.000171	0.00119	CcSEcCtD
Oxprenolol—Diarrhoea—Capecitabine—prostate cancer	0.000167	0.00117	CcSEcCtD
Oxprenolol—Dizziness—Docetaxel—prostate cancer	0.000167	0.00117	CcSEcCtD
Oxprenolol—Thrombocytopenia—Epirubicin—prostate cancer	0.000167	0.00117	CcSEcCtD
Oxprenolol—Hyperhidrosis—Epirubicin—prostate cancer	0.000165	0.00115	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—prostate cancer	0.000164	0.00115	CcSEcCtD
Oxprenolol—Dizziness—Capecitabine—prostate cancer	0.000162	0.00113	CcSEcCtD
Oxprenolol—Hypersensitivity—Prednisone—prostate cancer	0.00016	0.00112	CcSEcCtD
Oxprenolol—Hypotension—Epirubicin—prostate cancer	0.000159	0.00111	CcSEcCtD
Oxprenolol—Headache—Docetaxel—prostate cancer	0.000158	0.00111	CcSEcCtD
Oxprenolol—Asthenia—Prednisone—prostate cancer	0.000156	0.00109	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000155	0.00108	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—prostate cancer	0.000154	0.00108	CcSEcCtD
Oxprenolol—Pruritus—Prednisone—prostate cancer	0.000154	0.00108	CcSEcCtD
Oxprenolol—Insomnia—Epirubicin—prostate cancer	0.000154	0.00108	CcSEcCtD
Oxprenolol—Headache—Capecitabine—prostate cancer	0.000153	0.00107	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—prostate cancer	0.000152	0.00106	CcSEcCtD
Oxprenolol—Propranolol—CYP2C19—prostate cancer	0.00015	0.0237	CrCbGaD
Oxprenolol—Nausea—Docetaxel—prostate cancer	0.00015	0.00105	CcSEcCtD
Oxprenolol—Dyspepsia—Epirubicin—prostate cancer	0.00015	0.00105	CcSEcCtD
Oxprenolol—Propranolol—CYP1A1—prostate cancer	0.00015	0.0236	CrCbGaD
Oxprenolol—Diarrhoea—Prednisone—prostate cancer	0.000149	0.00104	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—prostate cancer	0.000147	0.00103	CcSEcCtD
Oxprenolol—Fatigue—Epirubicin—prostate cancer	0.000147	0.00103	CcSEcCtD
Oxprenolol—Nausea—Capecitabine—prostate cancer	0.000145	0.00101	CcSEcCtD
Oxprenolol—Dizziness—Prednisone—prostate cancer	0.000144	0.00101	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000144	0.001	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—prostate cancer	0.000142	0.000996	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—prostate cancer	0.000139	0.00097	CcSEcCtD
Oxprenolol—Headache—Prednisone—prostate cancer	0.000136	0.000953	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—prostate cancer	0.000136	0.00095	CcSEcCtD
Oxprenolol—Abdominal pain—Epirubicin—prostate cancer	0.000135	0.000941	CcSEcCtD
Oxprenolol—Nausea—Prednisone—prostate cancer	0.000129	0.000904	CcSEcCtD
Oxprenolol—Hypersensitivity—Epirubicin—prostate cancer	0.000125	0.000877	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—prostate cancer	0.000125	0.000871	CcSEcCtD
Oxprenolol—Asthenia—Epirubicin—prostate cancer	0.000122	0.000854	CcSEcCtD
Oxprenolol—Pruritus—Epirubicin—prostate cancer	0.00012	0.000842	CcSEcCtD
Oxprenolol—Diarrhoea—Epirubicin—prostate cancer	0.000116	0.000814	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—prostate cancer	0.000116	0.000811	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—prostate cancer	0.000113	0.00079	CcSEcCtD
Oxprenolol—Dizziness—Epirubicin—prostate cancer	0.000113	0.000787	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—prostate cancer	0.000111	0.000779	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—prostate cancer	0.000108	0.000754	CcSEcCtD
Oxprenolol—Headache—Epirubicin—prostate cancer	0.000107	0.000746	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—prostate cancer	0.000104	0.000728	CcSEcCtD
Oxprenolol—Nausea—Epirubicin—prostate cancer	0.000101	0.000707	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—prostate cancer	9.87e-05	0.00069	CcSEcCtD
Oxprenolol—Propranolol—CYP3A4—prostate cancer	9.55e-05	0.0151	CrCbGaD
Oxprenolol—Nausea—Doxorubicin—prostate cancer	9.36e-05	0.000654	CcSEcCtD
Oxprenolol—SLC22A2—Metabolism—NCOA1—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	1.79e-05	0.000191	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CALCA—prostate cancer	1.79e-05	0.00019	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP19A1—prostate cancer	1.77e-05	0.000189	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGFR4—prostate cancer	1.77e-05	0.000189	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PARP1—prostate cancer	1.77e-05	0.000189	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC22A3—prostate cancer	1.76e-05	0.000188	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD3B1—prostate cancer	1.76e-05	0.000188	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CALCA—prostate cancer	1.75e-05	0.000186	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL12—prostate cancer	1.75e-05	0.000186	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—RXRA—prostate cancer	1.71e-05	0.000182	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL12—prostate cancer	1.71e-05	0.000182	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA4—prostate cancer	1.69e-05	0.00018	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TBXAS1—prostate cancer	1.69e-05	0.00018	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—prostate cancer	1.67e-05	0.000177	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—COMT—prostate cancer	1.65e-05	0.000175	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA2—prostate cancer	1.65e-05	0.000175	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP9—prostate cancer	1.65e-05	0.000175	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTP1—prostate cancer	1.64e-05	0.000175	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	1.63e-05	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SULT1A1—prostate cancer	1.63e-05	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCG5—prostate cancer	1.63e-05	0.000173	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ITPR1—prostate cancer	1.62e-05	0.000172	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CD—prostate cancer	1.61e-05	0.000171	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP9—prostate cancer	1.61e-05	0.000171	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGFR—prostate cancer	1.6e-05	0.00017	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCQ—prostate cancer	1.6e-05	0.00017	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA1—prostate cancer	1.59e-05	0.000169	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	1.58e-05	0.000168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAP3K7—prostate cancer	1.58e-05	0.000168	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD3B2—prostate cancer	1.57e-05	0.000167	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTO1—prostate cancer	1.57e-05	0.000167	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NAT2—prostate cancer	1.57e-05	0.000167	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	1.56e-05	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGFR—prostate cancer	1.56e-05	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	1.54e-05	0.000164	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMS—prostate cancer	1.53e-05	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF10—prostate cancer	1.52e-05	0.000161	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—prostate cancer	1.51e-05	0.00016	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCB2—prostate cancer	1.51e-05	0.00016	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2C18—prostate cancer	1.51e-05	0.00016	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LRP2—prostate cancer	1.51e-05	0.00016	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB2—prostate cancer	1.5e-05	0.00016	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF10—prostate cancer	1.48e-05	0.000158	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPL—prostate cancer	1.48e-05	0.000157	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—JAK2—prostate cancer	1.48e-05	0.000157	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—P4HB—prostate cancer	1.48e-05	0.000157	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAP2K1—prostate cancer	1.47e-05	0.000157	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CD—prostate cancer	1.46e-05	0.000156	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VAV3—prostate cancer	1.46e-05	0.000156	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	1.45e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	1.44e-05	0.000153	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	1.44e-05	0.000153	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC22A1—prostate cancer	1.44e-05	0.000153	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	1.43e-05	0.000152	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VAV3—prostate cancer	1.43e-05	0.000152	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP1A1—prostate cancer	1.43e-05	0.000152	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ITPR1—prostate cancer	1.42e-05	0.000151	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ERCC2—prostate cancer	1.42e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	1.41e-05	0.00015	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	1.41e-05	0.000149	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SULT2A1—prostate cancer	1.4e-05	0.000149	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	1.39e-05	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MED12—prostate cancer	1.38e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	1.38e-05	0.000146	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNG5—prostate cancer	1.37e-05	0.000145	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	1.36e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	1.35e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	1.34e-05	0.000143	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—prostate cancer	1.33e-05	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	1.33e-05	0.000141	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	1.32e-05	0.000141	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA3—prostate cancer	1.32e-05	0.00014	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	1.31e-05	0.00014	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARA—prostate cancer	1.31e-05	0.000139	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LPL—prostate cancer	1.3e-05	0.000138	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	1.29e-05	0.000137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	1.29e-05	0.000137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	1.28e-05	0.000136	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LPL—prostate cancer	1.27e-05	0.000135	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	1.26e-05	0.000134	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	1.26e-05	0.000134	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HPGDS—prostate cancer	1.26e-05	0.000134	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	1.26e-05	0.000134	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2C19—prostate cancer	1.25e-05	0.000133	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	1.25e-05	0.000133	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAV1—prostate cancer	1.23e-05	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	1.23e-05	0.000131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	1.23e-05	0.00013	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ACHE—prostate cancer	1.22e-05	0.00013	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTT1—prostate cancer	1.22e-05	0.00013	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	1.22e-05	0.00013	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	1.22e-05	0.000129	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.2e-05	0.000128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	1.2e-05	0.000128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	1.19e-05	0.000127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	1.19e-05	0.000127	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	1.17e-05	0.000125	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.17e-05	0.000125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TERT—prostate cancer	1.17e-05	0.000124	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PRKACB—prostate cancer	1.17e-05	0.000124	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.15e-05	0.000123	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	1.15e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TERT—prostate cancer	1.14e-05	0.000121	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—prostate cancer	1.12e-05	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	1.12e-05	0.000119	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA2—prostate cancer	1.1e-05	0.000117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	1.09e-05	0.000116	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—prostate cancer	1.09e-05	0.000116	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	1.08e-05	0.000115	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—prostate cancer	1.07e-05	0.000114	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—prostate cancer	1.07e-05	0.000113	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—prostate cancer	1.06e-05	0.000113	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	1.06e-05	0.000112	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.05e-05	0.000112	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—prostate cancer	1.05e-05	0.000111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	1.04e-05	0.000111	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CREBBP—prostate cancer	1.04e-05	0.00011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.02e-05	0.000109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	1.02e-05	0.000108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BAD—prostate cancer	1.02e-05	0.000108	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NQO1—prostate cancer	1.01e-05	0.000108	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TH—prostate cancer	9.98e-06	0.000106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BAD—prostate cancer	9.94e-06	0.000106	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP3A4—prostate cancer	9.88e-06	0.000105	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CD—prostate cancer	9.85e-06	0.000105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APC—prostate cancer	9.84e-06	0.000105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	9.84e-06	0.000105	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	9.73e-06	0.000103	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGF—prostate cancer	9.73e-06	0.000103	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1B1—prostate cancer	9.71e-06	0.000103	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	9.63e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APC—prostate cancer	9.63e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	9.52e-06	0.000101	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGF—prostate cancer	9.52e-06	0.000101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	9.44e-06	0.0001	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GGT1—prostate cancer	9.41e-06	0.0001	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—prostate cancer	9.32e-06	9.91e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—prostate cancer	9.3e-06	9.89e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA1—prostate cancer	9.27e-06	9.85e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	9.24e-06	9.82e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP19A1—prostate cancer	9.13e-06	9.71e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	9.12e-06	9.7e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—prostate cancer	9.11e-06	9.69e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	9.01e-06	9.58e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	8.97e-06	9.53e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	8.93e-06	9.49e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	8.81e-06	9.37e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—RXRA—prostate cancer	8.81e-06	9.37e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	8.77e-06	9.33e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	8.71e-06	9.26e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	8.65e-06	9.2e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CB—prostate cancer	8.58e-06	9.12e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	8.57e-06	9.11e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	8.56e-06	9.1e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	8.52e-06	9.06e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—prostate cancer	8.5e-06	9.04e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—COMT—prostate cancer	8.49e-06	9.03e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	8.47e-06	9.01e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	8.46e-06	9e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTP1—prostate cancer	8.45e-06	8.98e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	8.38e-06	8.91e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	8.37e-06	8.9e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ITPR1—prostate cancer	8.31e-06	8.84e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	8.29e-06	8.81e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	8.28e-06	8.81e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	8.17e-06	8.69e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	8.1e-06	8.62e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	7.99e-06	8.5e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	7.94e-06	8.44e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMS—prostate cancer	7.86e-06	8.35e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	7.78e-06	8.27e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	7.77e-06	8.26e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—prostate cancer	7.76e-06	8.26e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	7.75e-06	8.24e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	7.64e-06	8.12e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPL—prostate cancer	7.62e-06	8.1e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	7.61e-06	8.09e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	7.58e-06	8.06e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	7.54e-06	8.02e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	7.47e-06	7.95e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTEN—prostate cancer	7.42e-06	7.88e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	7.38e-06	7.84e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1A1—prostate cancer	7.36e-06	7.83e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ERCC2—prostate cancer	7.3e-06	7.76e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	7.25e-06	7.71e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	7.09e-06	7.54e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	7.08e-06	7.52e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—EP300—prostate cancer	7.07e-06	7.52e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	7e-06	7.44e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	6.94e-06	7.37e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL2—prostate cancer	6.93e-06	7.36e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	6.92e-06	7.36e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	6.89e-06	7.33e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—prostate cancer	6.86e-06	7.3e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	6.85e-06	7.28e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	6.78e-06	7.21e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL2—prostate cancer	6.77e-06	7.2e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	6.75e-06	7.18e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	6.74e-06	7.17e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARA—prostate cancer	6.73e-06	7.16e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	6.69e-06	7.11e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	6.6e-06	7.02e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	6.55e-06	6.97e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	6.54e-06	6.95e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	6.53e-06	6.94e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	6.52e-06	6.93e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	6.41e-06	6.82e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	6.39e-06	6.79e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	6.37e-06	6.78e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	6.36e-06	6.76e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAV1—prostate cancer	6.33e-06	6.73e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	6.22e-06	6.61e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EP300—prostate cancer	6.21e-06	6.61e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EP300—prostate cancer	6.08e-06	6.46e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SRC—prostate cancer	6.04e-06	6.43e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SRC—prostate cancer	5.91e-06	6.29e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	5.89e-06	6.26e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	5.83e-06	6.2e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—prostate cancer	5.77e-06	6.13e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	5.76e-06	6.12e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	5.7e-06	6.06e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—prostate cancer	5.46e-06	5.8e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—prostate cancer	5.42e-06	5.76e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	5.4e-06	5.74e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CREBBP—prostate cancer	5.35e-06	5.68e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—prostate cancer	5.3e-06	5.63e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	5.3e-06	5.63e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	5.28e-06	5.62e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—prostate cancer	5.23e-06	5.56e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	5.18e-06	5.51e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.07e-06	5.39e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	5e-06	5.32e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	4.89e-06	5.2e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—prostate cancer	4.79e-06	5.09e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	4.6e-06	4.89e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	4.5e-06	4.78e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—prostate cancer	4.45e-06	4.73e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.42e-06	4.7e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—prostate cancer	4.38e-06	4.65e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—prostate cancer	4.35e-06	4.63e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—prostate cancer	4.27e-06	4.54e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—prostate cancer	4.07e-06	4.33e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—prostate cancer	3.98e-06	4.23e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTEN—prostate cancer	3.82e-06	4.06e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	3.76e-06	3.99e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	3.67e-06	3.91e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—EP300—prostate cancer	3.64e-06	3.87e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.69e-06	2.86e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—prostate cancer	2.2e-06	2.34e-05	CbGpPWpGaD
